Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
At the risk of sounding greedy, I’m a little disappointed with the share price over the last few weeks. I was hoping that the results and investor presentation would provide impetuous for a higher price but that has not happened. Perhaps the lack of a big COVID related contract, or the news that there would be no divi from Carclo for the next of couple of years dampened things a little. The director buying provides some reassurance though.
Thank you!
You can watch a copy of the weninar at: https://presentations.investormeetcompany.com/investor-meet-company/CARCLO-PLC-Preliminary-Results-for-the-year-ended-31-March-21?bmid=b90a0cdac95f
You may have to already be registered to watch it.
Will the presentation be available on the company’s website?
Gutted, listening g in my car and lost signal after about 10mins. Wanted to ask a couple of questions...
Must say though was encouraged with bit I did hear.
Will listen tomorrow now.
Agree...very solid presentation IMO.
Let's hope that the framework agreement with a 'major' OEM for the next 10 years is mentioned tomorrow.
I also agree that it is encouraging to see more director buying. It might be worth buying a few more on the strength of their confidence in the company.
Topped up this morning, thought I better get in early before the investor presentation which might trigger institutional buying !!!!!
I gave Phil White a new job.
That should read CFO
They know what’s in the pipeline?
Welcome to the shareholders list Phil White our CEO.
And a third vote of confidence from our Executive Chairman.
Good to see around £60,000 of shares bought by the Chairman and CFO post-results - quite a meaningful amount:
Https://uk.advfn.com/p.php?pid=news&symbol=L%5ECAR
The results today were what I imagined them to be (satisfactory) although I was surprised the sp was hammered so much. Hopefully the friday meeting will reveal essential tie-ups with covid-pharma and involvement in lateral flow testing.
An interesting comment from The European Centre for Disease Prevention and Control...who said last week that it estimates that by the end of August the delta variant will represent 90% of all Covid viruses circulating in the EU.
An appalling prospect but entirely predictable given that EU countries test a fraction of what the UK does (Poland for example has practically no testing and Macron has also recently made appalling decisions to open up against the advice of his health chiefs). The outlook therefore is for major increased demands for medical plastics until 2022 and beyond.
I may appear to be a carclo-optimist but if you can't make money producing medical plastics in a pandemic then when can you make money?
Topping-up for the umpteenth time is what I'll be doing!
"Carclo plc is pleased to announce that Nick Sanders, Executive Chairman, and Phil White, Chief Financial Officer, will provide a live presentation relating to the Preliminary Results for the year ended 31 March 2021 via the Investor Meet Company platform on 2 July 2021 at 11.45 am (BST).
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00 am (BST) on 1 July 2021 or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Carclo plc via the following link:
https://www.investormeetcompany.com/carclo-plc/register-investor"
So what questions should we be asking?
I think ahha was more articulate than me. My underwhelming comment was based upon the expectation that Covid business would reflect more in these results. Yes I was caught in the hype we have built up about this share
I agree it’s all Franks points, but hoped we would see more about Q1, to give an indication of where we were going.
Yes, there have been improvements and their is some hope that next year's figures will be better. But I am relieved that I only bought 5000 rather than 50,000 after the fall back from 70p!
I know how these markets operate as of old. Expectations are built up based on speculation and the value of the share overshoots,......everyone expects stellar results and after they are published the price falls back. Often the price falls even when the results are even better than the ones we have just been given. I'm holding my horses on this one for a while.
Well said Frankseluk
Someone said underwhelming.....
I honestly can't see what's underwhelming.
Debt reduced
Retirement liabilities reduced.
Net cash generated up.
Finished the year on an improving trend.
Management simplified and strengthened.
Encouraged by 1st quarter. With good progress expected current year.
Managed pandemic.
Looking after employees.
3 New large medical customers .
Increased demand from existing customers.
Going after new business
Please tell me what is underwhelming in That???
Jmo
I
Yes having given it a quick read through....encouraging progress.
They seem underwhelming
Better than expected!
Yes a crystal ball would come in handy!
We've been in a decent uptrend for some time and despite selling a few @65p i'm still holding most of them so i'd say medium term it's a solid hold. Personally i would never go all in on one share, but that's just my style and the way i manage my risk.
Oggy, I own 0.4% of Carclo so I suggest you stick everything on it instead of spreading it around. After wednesday it is likely to go up but very unlikely to go down. Q1 2021 may not be as wished-for but prospects for the rest of this year should be very positive. Good luck.
Oggy, if we knew the answer to your question we would be well on the way to being very rich indeed.
Take time and read some older posts, some posters/shareholders have taken an educated guess at the potential for the shares.
A lot now depends on the premlims due Wednesday and the companies review of the 1st quarter.
Also read company postings and updates. You might then get a better understanding of the companies worth and what it's shares price should or could be. Jmo. Good look whatever you decide.